References
- EOzer, JCGrecula, AAgrawal, CARhoades, DCYoung, DESchuller. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx. Laryngoscope 2006;116:607–12.
- RShiloh, SBialik, AKimchi. The DAPK family: a structure-function analysis. Apoptosis 2014;19:286–97.
- STPark, BRKim, SHPark, JHLee, EJLee, SHLee, et al. Suppression of VEGF expression through interruption of the HIF 1alpha and Akt signaling cascade modulates the anti angiogenic activity of DAPK in ovarian carcinoma cells. Oncol Rep 2014;31:1021–9.
- NLaytragoon-Lewin, LERutqvist, FLewin. DNA methylation in tumour and normal mucosal tissue of head and neck squamous cell carcinoma (HNSCC) patients: new diagnostic approaches and treatment. Med Oncol 2013;30:654.
- EUehara, STakeuchi, YYang, TFukumoto, YMatsuhashi, TTamura, et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. Oncol Lett 2012;3:190–2.
- SPierini, SHJordanov, AVMitkova, IJChalakov, MBMelnicharov, KVKunev, et al. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients. Head Neck 2014;36:1103–8.
- SCPack, HRKim, SWLim, HYKim, JYKo, KSLee, et al. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer. Int J Colorectal Dis 2013;28:139–47.
- ATserga, NVMichalopoulos, GLevidou, PKorkolopoulou, GZografos, EPatsouris, et al. Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncol Rep 2012;27:1630–8.
- MEsteller, MSanchez-Cespedes, RRosell, DSidransky, SBBaylin, JGHerman. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67–70.
- KKawaguchi, YOda, TSaito, HYamamoto, TTakahira, STamiya, et al. Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. Hum Pathol 2004;35:1266–71.
- YDong, HZhao, HLi, XLi, SYang. DNA methylation as an early diagnostic marker of cancer (Review). Biomed Rep 2014;2:326–30.
- VLevin-Salomon, SBialik, AKimchi. DAP-kinase and autophagy. Apoptosis 2014;19:346–56.
- YHuang, LChen, LGuo, TRHupp, YLin. Evaluating DAPK as a therapeutic target. Apoptosis 2014;19:371–86.
- JLKissil, EFeinstein, OCohen, PAJones, YCTsai, MAKnowles, et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 1997;15:403–7.
- DGozuacik, AKimchi. DAPk protein family and cancer. Autophagy 2006;2:74–9.
- BInbal, OCohen, SPolak-Charcon, JKopolovic, EVadai, LEisenbach, et al. DAP kinase links the control of apoptosis to metastasis. Nature 1997;390:180–4.
- HYChen, YMLin, HCChung, YDLang, CJLin, JHuang, et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 2012;72:3631–41.
- HYChen, YRLee, RHChen. The functions and regulations of DAPK in cancer metastasis. Apoptosis 2014;19:364–70.
- XJLuo, LLLi, QPDeng, XFYu, LFYang, FJLuo, et al. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells. Eur J Cancer 2011;47:316–25.
- JWang, XLPan, LJDing, DYLiu, DPLei, TJin. Aberrant expression of Beclin-1 and LC3 correlates with poor prognosis of human hypopharyngeal squamous cell carcinoma. PLoS One 2013;8:e69038.